Nasdaq: CTKB

Cytek Biosciences, Inc. (CTKB)

Cytek Biosciences, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker CTKB. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
CTKB
Exchange
Nasdaq
SEC CIK
1831915
Official filings
SEC EDGAR

Research CTKB

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Cytek Biosciences, Inc.'s stock ticker?

Cytek Biosciences, Inc. trades under the ticker symbol CTKB on Nasdaq. Its SEC Central Index Key (CIK) is 1831915.

Where can I read Cytek Biosciences, Inc.'s SEC filings?

The CTKB SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Cytek Biosciences, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze CTKB's financial statements?

The CTKB Financials page shows Cytek Biosciences, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does CTKB compare with its peers and the market?

The CTKB Peer Comparison page lines Cytek Biosciences, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.